Marksans Pharma Share

Marksans Pharma Ltd.

TASC Industries (India) Ltd. was incorporated on 16th April 1992 as a Public Limited Company under the Companies Act 1956 at Bombay in the state of Maharshtra. The certificate of commencement of business was obtained on 5th June 1992. The company has been promoted by Mr. Vijay Thakkar, Mr. Sanjay Thakkar and Mr. Sanjay Sahu to set up a plant for manufacture of Ciprofloxacin, Chloramphenicol and Chloramphenicol Palmoate. The promoters have been trading in bulk drugs and formulations for the past eight years through their associate concern Tasc Chemical India Pvt. Ltd.

2005 -Company has changed its name from Tasc Pharmaceuticals Ltd. to Marksans Pharma Ltd.

2008 - The Company has splits its face value from Rs10/- to Rs1/-.

Marksans Pharma Limited announces USFDA approval of generic Ibuprofen Capsules (Liquid Filled), 200 mg for Advil Liqui - Gels 200 mg.

2010 -Company has entered into a Business Transfer Agreement with Kores (India) Limited

2014 -Marksans Pharma Ltd has recommended dividend of 10% which is Rs. 0.10 per equity share of Rs. 1/- each face value.

 2015 -Marksans Pharma gains on acquiring Time-Cap Laboratories

2016 -Marksans Pharma gets USFDA nod for Paricalcitol capsules -Marksans Pharma gets USFDA nod for diabetes treatment drug -Marksans Pharma bags USFDA approval for Loratadine.

Market Capital: ₹1,388 Cr              Enterprise Value: ₹1,313 Cr

Book Value: ₹15.54

Current Price: ₹33.90         >           Face Value: ₹1.00

52 week High/Low: ₹37.20/9.85

Stock P/E: 11.49                 >            Industry P/E: 17.77

Dividend Yield: 0.15%        <            Earnings Yield: 12.64%

ROCE: 18.51%                   >            ROE: 15.09%

Sales Growth: 12.44%         >            Profit Growth: 50.13%

Debt/Equity: 0.03

Debt: ₹18.84 Cr.

Contingent Liabilities: ₹0.00 Cr

Interest Coverage Ratio: 18.96

Current Ratio: 2.69

PEG Ratio: 19.27

Promoter Holdings: 48.25%

Pledged percentage: 0.00%

Retail Shareholding: % approx

   Sales Growth                                  Profit Growth                

10 Years: 10.88%                              10 Years: 27.48%      

 5 Years:    9.68%                               5 Years:  1.24%

 3 Years:    3.83%                               3 Years: -0.87%

    TTM: 12.44%                                    TTM: 50.13%   

Note:

Ques: What is working for the company ?

1. Company has good consistent profit growth of 9.68% over 5 years.
2. Return on Equity growing consistently at rate 15.09%
3. Reserve(₹595 Cr) is greater than its borrowings(19 Cr).
4. Net Cash Flow is still positive.
5. Company is virtually Debt Free.
6. EPS is growing.
7. Delivery %age of Shares is 57%.

Ques: What is Risk Involved in this company?

1. Dividend payout has been low at 10.68% of profits over last 3 years.